Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations

Resistance to chemotherapy, enhanced proliferation, invasion, angiogenesis, and metastasis (RPIAM) represent major obstacles that limit the efficacy of cancer treatment especially in advanced stages of cancer. Overcoming or suppressing RPIAM can dramatically improve the treatment outcome. Non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Joydeb, Minko, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309189/
https://www.ncbi.nlm.nih.gov/pubmed/34371754
http://dx.doi.org/10.3390/pharmaceutics13071063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309189/
https://www.ncbi.nlm.nih.gov/pubmed/34371754
http://dx.doi.org/10.3390/pharmaceutics13071063

Ejemplares similares